10-Q/A XBRL

10-Q/A Filing

Company: ENDONOVO THERAPEUTICS, INC.
Filed: November 9, 2017
Period of Report: September 30, 2017
Accession Number: 0001493152-17-012663

View Document ↗ View on SEC.gov ↗